← FDA DRUG APPROVALS

FDA NDA · NDA219873

DESMODA

desmopressin acetate oral solution

Sponsor: ETON

APPLICATION
NDA219873
TYPE
NDA
ORIGINAL APPROVAL
2026-02-25
LATEST ACTION
2026-02-25
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

DESMODA · ReferencePrescription
DESMOPRESSIN ACETATE 0.05MG/ML · SOLUTION · ORAL

Approval history

2026-02-25Type 3 - New Dosage Form · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →